Moderna Shares Fall About 25% After Cancer-Vaccine Data Leak
Moderna shares fell around 25% after details from a closely guarded mRNA cancer-vaccine study were shared on social media, putting the stock on pace for its largest decline since the company went public.
Story updates
06:52:25 PM UTC
SquawkNews
By Mackenzie TatananniModerna stock plunged 25% on Thursday following a data leak about the cancer vaccine candidate the drugmaker is co-developing with Merck.The data, which was set to be presented at the annual meeting of the European Society for Medical Oncology over the weekend, was reported by…
Moderna shares plunged after details from a closely guarded mRNA-based cancer-vaccine study were shared on social media.Moderna's stock fell around 25%, putting the Cambridge, Mass., biotech on pace for its largest decrease since it went public.In August, Moderna and its partner Merck said the vacc…